(Q42232746)

English

Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

scientific article published on 10 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

ChEBI release 2020-05-28

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Mika Miura

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Shinya Maekawa

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Mitsuaki Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Nobutoshi Komatsu

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Akihisa Tatsumi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Shinichi Takano

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Fumitake Amemiya

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yasuhiro Nakayama

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Taisuke Inoue

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Minoru Sakamoto

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Nobuyuki Enomoto

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

10 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

E360-7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Antiviral strategies in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Preliminary study of two antiviral agents for hepatitis C genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Interferon free regimens for the "difficult-to-treat": are we there?

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Sequence requirements for the development of a chimeric HCV replicon system

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Combinations of lambda interferon with direct-acting antiviral agents are highly efficient in suppressing hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12316

21 January 2018

Identifiers

10.1111/HEPR.12316

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42232746&oldid=1937386392"